CHANDAN vs ZOTA: Stock Comparison

CHANDAN vs ZOTA HEALTH CAREUpdated 18 Sept 26, 4:08 PM ISTNSE & company filings

ZOTA HEALTH CARE is the larger company by market capitalisation. CHANDAN shows a higher ROE, a higher ROCE and a higher net margin, while ZOTA HEALTH CARE shows a lower P/E, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

CHANDAN leads 6; ZOTA leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

CHANDANZOTA

Valuation lens

What price are you paying?

Market CapContext only
₹495 Cr
₹3,948 Cr
P/E RatioZOTA has the lower reading
22.4x
0x
P/B RatioCHANDAN has the lower reading
3.55x
5.69x
EPSCHANDAN has the higher reading
₹2.74
₹0.55
Book ValueContext only
₹72.1
₹201.01
Dividend YieldZOTA has the higher reading
0%
0.09%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ZOTA is the larger company
₹3,948 Cr vs ₹495 Cr
P/E Ratio
ZOTA has a lower P/E
0x vs 22.4x
P/B Ratio
CHANDAN has a lower P/B
3.55x vs 5.69x
EPS
CHANDAN has higher earnings per share
₹2.74 vs ₹0.55
Dividend Yield
ZOTA has a higher dividend yield
0.09% vs 0%
Revenue Growth (TTM YoY)
ZOTA has faster revenue growth
67.7% vs 0%
Qtr Sales Growth
ZOTA has stronger quarterly sales growth
-26.83% vs -39.81%
Qtr Profit Growth
ZOTA has stronger quarterly profit growth
104.32% vs -10.49%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricCHANDANZOTA
SectorHealthcare
IndustryPharmaceuticals

Price

MetricCHANDANZOTA
Live Price₹1,144.5
Day Change2.3%
Volume56,557
52-Week High₹1,740
52-Week Low₹1,022
Distance from 52W High-34.22%

Valuation

MetricCHANDANZOTA
Market Cap₹495 Cr₹3,948 Cr
P/E Ratio22.4x0x
P/B Ratio3.55x5.69x
EPS₹2.74₹0.55
Book Value₹72.1₹201.01
Dividend Yield0%0.09%

Growth

MetricCHANDANZOTA
Revenue Growth (TTM YoY)0%67.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-39.81%-26.83%
Qtr Profit Growth-10.49%104.32%

Profitability & Leverage

MetricCHANDANZOTA
ROE16.2%3.14%
ROCE14.55%3.76%
Net Margin0%-13.98%
Operating Margin15.97%9.83%
Debt to Equity0.3x0.02x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricCHANDANZOTA
Promoter Holding49.61% 0.06 pp49.38%
FII Holding0.01%7.92% 0.29 pp
DII Holding5.09% 0.06 pp6.75% 0.35 pp
Public Holding45.29% 0.13 pp35.96% 0.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: CHANDAN and ZOTA HEALTH CARE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.